CRBU
Price
$2.56
Change
-$0.00 (-0.00%)
Updated
Nov 5 closing price
138 days until earnings call
FATE
Price
$2.68
Change
-$0.00 (-0.00%)
Updated
Nov 5 closing price
116 days until earnings call
Ad is loading...

CRBU vs FATE

Header iconCRBU vs FATE Comparison
Open Charts CRBU vs FATEBanner chart's image
Caribou Biosciences
Price$2.56
Change-$0.00 (-0.00%)
Volume$2.96M
CapitalizationN/A
Fate Therapeutics
Price$2.68
Change-$0.00 (-0.00%)
Volume$1.29M
CapitalizationN/A
View a ticker or compare two or three
CRBU vs FATE Comparison Chart
Loading...
CRBU
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
FATE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CRBU vs. FATE commentary
Nov 07, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a Buy and FATE is a Buy.

COMPARISON
Comparison
Nov 07, 2024
Stock price -- (CRBU: $2.56 vs. FATE: $2.80)
Brand notoriety: CRBU and FATE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 287% vs. FATE: 145%
Market capitalization -- CRBU: $248.95M vs. FATE: $318.86M
CRBU [@Biotechnology] is valued at $248.95M. FATE’s [@Biotechnology] market capitalization is $318.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.24B to $0. The average market capitalization across the [@Biotechnology] industry is $2.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileFATE’s FA Score has 1 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • FATE’s FA Score: 1 green, 4 red.
According to our system of comparison, both CRBU and FATE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 6 TA indicator(s) are bullish while FATE’s TA Score has 4 bullish TA indicator(s).

  • CRBU’s TA Score: 6 bullish, 4 bearish.
  • FATE’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CRBU is a better buy in the short-term than FATE.

Price Growth

CRBU (@Biotechnology) experienced а +32.64% price change this week, while FATE (@Biotechnology) price change was +12.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.05%. For the same industry, the average monthly price growth was +13.31%, and the average quarterly price growth was +11.52%.

Reported Earning Dates

CRBU is expected to report earnings on Mar 24, 2025.

FATE is expected to report earnings on Mar 03, 2025.

Industries' Descriptions

@Biotechnology (+1.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FATE($319M) has a higher market cap than CRBU($249M). FATE YTD gains are higher at: -25.134 vs. CRBU (-55.323). CRBU has higher annual earnings (EBITDA): -137.69M vs. FATE (-176.34M). FATE has more cash in the bank: 305M vs. CRBU (262M). CRBU has less debt than FATE: CRBU (26.8M) vs FATE (101M). CRBU has higher revenues than FATE: CRBU (33.1M) vs FATE (12.3M).
CRBUFATECRBU / FATE
Capitalization249M319M78%
EBITDA-137.69M-176.34M78%
Gain YTD-55.323-25.134220%
P/E RatioN/AN/A-
Revenue33.1M12.3M269%
Total Cash262M305M86%
Total Debt26.8M101M27%
FUNDAMENTALS RATINGS
FATE: Fundamental Ratings
FATE
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBUFATE
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
56%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
CRBU
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
FATE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NESIX20.150.82
+4.24%
Needham Small Cap Growth Institutional
OEGIX36.481.25
+3.55%
Invesco Discovery Mid Cap Growth R6
MSXMX65.861.63
+2.54%
NYLI S&P 500 Index SIMPLE Class
WCMGX27.930.37
+1.34%
First Trust WCM Focused Global Gr Inst
GEMOX12.67N/A
N/A
Goldman Sachs Emerging Mkt Eq ex. ChnInv

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with ALLO. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then ALLO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
+9.40%
ALLO - CRBU
52%
Loosely correlated
-0.33%
FATE - CRBU
52%
Loosely correlated
-2.90%
BEAM - CRBU
52%
Loosely correlated
-1.77%
AXON - CRBU
50%
Loosely correlated
+2.21%
NTLA - CRBU
50%
Loosely correlated
+1.92%
More